or
forgot password

    • cancer clinical trials in bethlehem, PA

    • Temozolomide, Vincristine, and Irinotecan in Treating Young Patients With Refractory Solid Tumors
    Lehigh Valley Hospital - Muhlenberg
    Bethlehem, Pennsylvania 18017
    Brain and Central Nervous System Tumors, Unspecified Childhood Solid Tumor, Protocol Specific
    Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Had Surgery for Stage II or Stage III Rectal Cancer (Groups I and II Closed to Accrual as of 4/29/2009)
    Saint Luke's Hospital
    Bethlehem, Pennsylvania 18015
    Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer
    Irinotecan and Temozolomide in Treating Young Patients With Recurrent Neuroblastoma
    Lehigh Valley Hospital - Muhlenberg
    Bethlehem, Pennsylvania 18017
    Neuroblastoma
    Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
    Lehigh Valley Hospital - Muhlenberg
    Bethlehem, Pennsylvania 18017
    B-cell Childhood Acute Lymphoblastic Leukemia, L1 Childhood Acute Lymphoblastic Leukemia, L2 Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Lymphoblastic Leukemia
    Assessment and Tracking of Long-term Alefacept Safety
    Lehigh Valley Dermatology
    Bethlehem, Pennsylvania 18018
    Psoriasis
    A Phase 1 Study Investigating the Combination of RAD001, Cetuximab and Irinotecan as Second-line Therapy After FOLFOX (or XELOX) Plus Bevacizumab in Patients With Metastatic Colorectal Cancer
    Oncology/Hematology Associates
    Bethlehem, Pennsylvania 18017
    Colorectal Cancer, Colorectal Carcinoma, Colorectal Tumors, Neoplasms, Colorectal
    cRisk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Lehigh Valley Hospital - Muhlenberg
    Bethlehem, Pennsylvania 18017
    Leukemia
    Trial of Dacarbazine With or Without Genasense in Advanced Melanoma
    St. Luke's Cancer Center
    Bethlehem, Pennsylvania 18015
    Melanoma
    Nilotinib vs Imatinib in Adult Patients With Philadelphia (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)
    St. Luke's Hospital and Health Network
    Bethlehem, Pennsylvania 18015
    Myelogenous Leukemia
    Phase 2 Study of Intralesional PV-10 for Metastatic Melanoma
    St Luke's Hospital & Health Network
    Bethlehem, Pennsylvania 18015
    Melanoma
    Elesclomol (STA-4783) With Paclitaxel Versus Paclitaxel Alone in Melanoma
    St. Luke's Cancer Center
    Bethlehem, Pennsylvania 18015
    Melanoma
    Phase II Study to Evaluate Efficacy and Safety of RP101 in Combination With Gemcitabine
    St. Luke's Cancer Center
    Bethlehem, Pennsylvania 18015
    Pancreatic Cancer
    Aflibercept Versus Placebo in Combination With Irinotecan and 5-FU in the Treatment of Patients With Metastatic Colorectal Cancer After Failure of an Oxaliplatin Based Regimen
    Sanofi-Aventis Investigational Site Number 840118
    Bethlehem, Pennsylvania 18015
    Colorectal Neoplasms, Neoplasm Metastasis
    Bio-Seal Biopsy Track Plug for Reducing Pneumothorax Rates Post Lung Biopsy Procedure
    St Lukes Hospital
    Bethlehem, Pennsylvania 18015
    Pneumothorax
    Safety and Efficacy of Pasireotide Long Acting Release vs. Octreotide Long Acting Release in Patients With Metastatic Carcinoid Disease
    St. Luke's Hospital and Health Network St. Luke's Cancer Network
    Bethlehem, Pennsylvania
    Symptomatic Refractory Resistant Carcinoid Disease
    Safety and Efficacy of Bevacizumab Plus RAD001 Versus Interferon Alfa-2a and Bevacizumab in Adult Patients With Kidney Cancer
    St. Luke's Hospital and Health Network St. Luke's Cancer Network
    Bethlehem, Pennsylvania
    Carcinoma, Renal Cell, Adenocarcinoma, Renal Cell, Nephroid Carcinoma, Carcinoma, Hypernephroid
    A Study of ASA404 or Placebo in Combination With Docetaxel in Second-line Treatment for (Stage IIIb/IV) Non-small Cell Lung Cancer
    St. Luke's Hospital & Healtth Network
    Bethlehem, Pennsylvania 18015
    Non-Small Cell Lung Cancer
    Trial of CPX-351 in Adult Patients With First Relapse Acute Myeloid Leukemia (AML)
    Oncology and Hematology at Lehigh Valley
    Bethlehem, Pennsylvania 18105
    Acute Myeloid Leukemia
    Comparison of Ipilimumab Manufactured by 2 Different Processes in Participants With Advanced Melanoma
    St Luke'S Hospital And Health Network
    Bethlehem, Pennsylvania 18015
    Advanced Melanoma
    A Study of YM155 Plus Docetaxel in Subjects With Stage III (Unresectable) or Stage IV Melanoma
    St. Lukes Hospital Cancer Center
    Bethlehem, Pennsylvania 18015
    Melanoma
    Effect of Cabazitaxel on the QTc Interval in Cancer Patients
    Sanofi-Aventis Investigational Site Number 840009
    Bethlehem, Pennsylvania 18015
    Neoplasms, Malignant
    Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
    St. Luke's Cancer Center
    Bethlehem, Pennsylvania 18015
    Metastatic Pancreatic Cancer
    Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Unresectable or Metastatic NRAS Mutation-positive Melanoma
    St. Luke's Hospital and Health Network SC
    Bethlehem, Pennsylvania
    Metastatic or Unresectable Cutaneous Melanoma